Detalhe da pesquisa
1.
Follicular lymphoma evolves with a surmountable dependency on acquired glycosylation motifs in the B-cell receptor.
Blood
; 142(26): 2296-2304, 2023 12 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37683139
2.
Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast Tumors.
J Immunol
; 211(2): 295-305, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37256255
3.
CD81 costimulation skews CAR transduction toward naive T cells.
Proc Natl Acad Sci U S A
; 119(5)2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35091467
4.
Single-cell analysis can define distinct evolution of tumor sites in follicular lymphoma.
Blood
; 137(21): 2869-2880, 2021 05 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33728464
5.
Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens.
Nature
; 543(7647): 723-727, 2017 03 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-28329770
6.
Fingolimod-Conjugated Charge-Altering Releasable Transporters Efficiently and Specifically Deliver mRNA to Lymphocytes In Vivo and In Vitro.
Biomacromolecules
; 23(7): 2976-2988, 2022 07 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35748182
7.
Single-cell RNA-Seq of follicular lymphoma reveals malignant B-cell types and coexpression of T-cell immune checkpoints.
Blood
; 133(10): 1119-1129, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30591526
8.
Distinct patterns of B-cell receptor signaling in non-Hodgkin lymphomas identified by single-cell profiling.
Blood
; 129(6): 759-770, 2017 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28011673
9.
T-Cell Immunopeptidomes Reveal Cell Subtype Surface Markers Derived From Intracellular Proteins.
Proteomics
; 18(12): e1700410, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29493099
10.
Therapeutic antitumor immunity by checkpoint blockade is enhanced by ibrutinib, an inhibitor of both BTK and ITK.
Proc Natl Acad Sci U S A
; 112(9): E966-72, 2015 Mar 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-25730880
11.
Ibrutinib enhances the antitumor immune response induced by intratumoral injection of a TLR9 ligand in mouse lymphoma.
Blood
; 125(13): 2079-86, 2015 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-25662332
12.
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies.
Blood
; 123(5): 678-86, 2014 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-24326534
13.
B-cell lymphomas present immunoglobulin neoantigens.
Blood
; 133(8): 878-881, 2019 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30545830
14.
High PD-1 expression and suppressed cytokine signaling distinguish T cells infiltrating follicular lymphoma tumors from peripheral T cells.
Blood
; 121(8): 1367-76, 2013 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-23297127
15.
In situ vaccination against mycosis fungoides by intratumoral injection of a TLR9 agonist combined with radiation: a phase 1/2 study.
Blood
; 119(2): 355-63, 2012 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-22045986
16.
A clinical trial of therapeutic vaccination in lymphoma with serial tumor sampling and single-cell analysis.
Blood Adv
; 8(1): 130-142, 2024 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37939259
17.
CD137 is expressed in follicular dendritic cell tumors and in classical Hodgkin and T-cell lymphomas: diagnostic and therapeutic implications.
Am J Pathol
; 181(3): 795-803, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22901750
18.
A CpG-loaded tumor cell vaccine induces antitumor CD4+ T cells that are effective in adoptive therapy for large and established tumors.
Blood
; 117(1): 118-27, 2011 Jan 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-20876455
19.
Donor immunization with WT1 peptide augments antileukemic activity after MHC-matched bone marrow transplantation.
Blood
; 118(19): 5319-29, 2011 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21868578
20.
CD137 stimulation enhances the antilymphoma activity of anti-CD20 antibodies.
Blood
; 117(8): 2423-32, 2011 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21193697